Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Oct 18:11:1441573.
doi: 10.3389/fmed.2024.1441573. eCollection 2024.

Case report: Novel deletions in the 6p21.33 involving the CSNK2B gene in patients with Poirier-Bienvenu neurodevelopmental syndrome and literature review

Affiliations
Case Reports

Case report: Novel deletions in the 6p21.33 involving the CSNK2B gene in patients with Poirier-Bienvenu neurodevelopmental syndrome and literature review

Xuan Zhang et al. Front Med (Lausanne). .

Abstract

Background: Seizures have been identified in most patients with CSNK2B-related Poirer-Bienvenu Neurodevelopment syndrome (POBINDS). Detailed descriptions of seizure phenotypes, various genotypes, and long-term follow-up visits are required for clinicians to provide reasonable clinical management for such patients.

Case summary: We report two new Chinese patients with varying sizes of 6p21.33 deletions encompassing the CSNK2B gene who presented with intellectual disability and seizures. Furthermore, we conducted a literature review of previously reported patients with 6p21.33 deletions or CSNK2B variants. We summarized and analyzed the clinical characteristics of these patients with seizures. The occurrence of a biphasic pattern of epilepsy and pharmacoresistant epilepsy in patients with CSNK2B variants is severely underestimated. One of our patients underwent a long follow-up period and presented with comprehensive disease progression.

Conclusion: Our data suggest that the CSNK2B variant or 6p21.33 deletion should be considered in patients with intellectual disability and epilepsy, especially those characterized by biphasic patterns and digital anomalies.

Keywords: 6p21.33 deletion; CNSK2B; POBINDS; biphasic patterns; digital anomalies; epilepsy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Digital anomalies of patient 1.
FIGURE 2
FIGURE 2
EEG and Imaging data of patient 1. (A–C) EEG of patient 1 at 20 years old, 23 years old and 24 years old. Background of EEG slows down at 20 years old (A), paroxysmal slow waves lasting for less than 3 s at 23 years old (B), lasting for 20–30 s at 24 years old (C). Progressive slowing of the electroencephalographic (EEG) background is prominent. (D) EEG of patient 1 at 24 years old. The ictal EEG was characterized by right cerebral focus with diffused electrodecremental event, subsequently evolving into bilateral hemispheres. (E) MRI images of patient 1 at 23 years. MRI: revealed abnormal signal in right-sided centrum semiovale.
FIGURE 3
FIGURE 3
Schematic representation of 6p21.33 deletions in three cases from the UCSC Genome Browser. Gray-shaded area shows the area of 6p21.33 deletion in patient 1. Pink-shaded area shows the area of 6p21.33 deletions in patient 2. Purple-shaded area shows the area of 6p21.33 deletion in patient of Ikuko et al. The black arrow shows CSNK2B gene.

Similar articles

References

    1. Poirier K, Hubert L, Viot G, Rio M, Billuart P, Besmond C, et al. CSNK2B splice site mutations in patients cause intellectual disability with or without myoclonic epilepsy. Hum Mutat. (2017) 38:932–41. 10.1002/humu.23270 - DOI - PubMed
    1. Borgo C, D’Amore C, Sarno S, Salvi M, Ruzzene M. Protein kinase CK2: A potential therapeutic target for diverse human diseases. Signal Transduct Target Ther. (2021) 6:183. 10.1038/s41392-021-00567-7 - DOI - PMC - PubMed
    1. Kravic B, Harbauer A, Romanello V, Simeone L, Vögtle F, Kaiser T, et al. In mammalian skeletal muscle, phosphorylation of TOMM22 by protein kinase CSNK2/CK2 controls mitophagy. Autophagy. (2018) 14:311–35. 10.1080/15548627.2017.1403716 - DOI - PMC - PubMed
    1. Di Stazio M, Zanus C, Faletra F, Pesaresi A, Ziccardi I, Morgan A, et al. Haploinsufficiency as a foreground pathomechanism of Poirer-Bienvenu syndrome and novel insights underlying the phenotypic continuum of CSNK2B-associated disorders. Genes (Basel). (2023) 14:250. 10.3390/genes14020250 - DOI - PMC - PubMed
    1. Ernst M, Baugh E, Thomas A, Bier L, Lippa N, Stong N, et al. CSNK2B: A broad spectrum of neurodevelopmental disability and epilepsy severity. Epilepsia. (2021) 62:e103–9. 10.1111/epi.16931 - DOI - PMC - PubMed

Publication types

LinkOut - more resources